The 19th CPHI China was held in Shanghai New International Expo Center on June 18-20, 2019, with an exhibition area of more than 200000 square meters and 17 pavilions, attracting more than 3200 domestic and foreign exhibitors and 70000 visitors.

    As a professional manufacturer of anti-tumor raw materials, animal and plant derived raw materials, and their derivatives, Xieli Pharmaceutical has obtained official certifications from SFDA, MHRA, EDQM, FDA, PMDA, and COFEPRIS. It also has independent research and development centers, pilot platforms, and production capabilities ranging from grams to tons, as well as granulation and micro powder production. It provides customized services and joint applications at home and abroad.

    At this grand event, our joint pharmaceutical booth is located in the API&CMO themed exhibition hall - E2P26.

    During the exhibition, there were meetings with old customers, visits from new customers, and a surge of people at the booth. Here, we sincerely thank every customer and friend who came to the Xieli Pharmaceutical booth.

     Although the 3-day exhibition has come to an end, our dreams continue. Xieli Pharmaceutical will continue to innovate and provide more cost-effective products and higher quality services to our trusted customers and friends. In order to achieve this goal, we are constantly striving. I hope you can witness the growth of cooperation and share the joy of the harvest of cooperation together

    CPHI Worldwide 2019, November 5-7 Booth: 41L26

    Xieli Pharmaceutical cordially invites you to meet again in Frankfurt!

    Looking forward to working together with you to create a better future!